Articles & Video
Andreas Diacon, TASK Applied Science, announced as winner of Christine Pierre Lifetime Achievement Award 2019
At this year's Clinical Trials Europe, the Christine Pierre Lifetime Achievement Award 2019 was presented to Andreas Diacon, Founder, Director and & CEO at TASK Applied Science.
Life Sciences in 2020: Predictions from industry insiders
Industry insiders predict how life sciences will change in 2020 in emerging therapies, clinical trials, regulations and agriculture.
The Top 10 Posts of 2019: Clinical Trials Innovation
We look back at 2019's most popular articles on innovating clinical trials in an interactive flip-book.
How far can we trust AI in clinical trials?- INDUSTRY VOICES
Seven industry experts tell us what they see as the greatest challenges in using AI in clinical trials and how they can best be solved.
Virtual trials and Real World Evidence: The global shift in clinical operations
We deep-dive into our State of the Industry Report 2019 to understand how companies are utilizing virtual trials and Real World Evidence in their clinical trial operations.
Is AI really understood in the clinical trials industry? - Data report analysis
The latest State of the Industry 2019 survey revealed fascinating insights into what opportunities and obstacles organisations currently see in working with AI in clinical trials.
Emerging conventions in early clinical development - data report analysis
While exploring how organisations are currently innovating early clinical development, our latest State of the Industry survey revealed interesting insights.
Leveraging Real World Evidence for drug approval
Since the introduction of the 21st Century Cures Act real world evidence has been gaining in popularity. We look at the opportunities and challenges it presents.
Real World Evidence: Revolutionizing the Clinical Trials Environment - WHITEPAPER
Download this exclusive whitepaper exploring how Real World Evidence is revolutionizing the clinical trials environment.
How Virtual Trials and Real World Evidence are changing the CRO landscape
Dr. Raphaela Schnurbus, Clinical Solutions & Business Development Director at CRO OPIS, explores how Virtual Trials and Real World Evidence could change the clinical trials of the future.
Real-World-Evidence Mythbusting: 5 myths holding back patient-reported RWE adoption
What is holding back patient-reported Real-World-Evidence adoption in clinical trials? Bruce Hellman, CEO and Co-founder at uMotif, busts 5 myths.
How technology is changing clinical trials – INDUSTRY VOICES
We asked six professionals from pharma, CROs, networks and sites about how they think technology is changing clinical trials.
MHealth in clinical trials: 79% of companies increasing usage - data report analysis
We analyse the data around mHealth in clinical trials implementation, benefits and challenges from our recent clinical survey.
INDUSTRY REPORT: Beyond the Hype in Clinical Trials
Download our report based on 199 survey responses exploring the impact trends are having on clinical trials including mHealth, AI, patient-centricity and M&As.